GLAXO profit soars 154% YoY in half-year results

August 26, 2025 (MLN): GlaxoSmithKline Pakistan Limited (PSX: GLAXO) posted a strong financial performance for the half-year ended June 30, 2025, with profit after taxation jumping 153.63% YoY to Rs4.20 billion [EPS: Rs13.17], compared to Rs1.65 billion [EPS: Rs5.19] in the same period last year.

Sales increased 4.95% YoY to Rs30.31bn from Rs28.87bn, while the cost of sales declined by 16.14% YoY to Rs19.60bn, resulting in a robust improvement in gross profit, which nearly doubled by 94.57% YoY to Rs10.70bn.

On the expense side, selling, marketing and distribution expenses rose 23.90% YoY to Rs2.59bn, whereas administrative expenses remained broadly stable, dipping 0.54% YoY to Rs1.02bn. Other operating expenses spiked by 146.01% YoY to Rs613.54m.

Meanwhile, other income fell 16.56% YoY to Rs744.79m. Despite this, operating profit surged 138.38% YoY to Rs7.23bn.

Finance charges edged down slightly by 1.00% YoY to Rs214.42m, lifting profit before levies and income tax by 149.09% YoY to Rs7.01bn. After accounting for levies of Rs47.06m (up 8.63% YoY), profit before taxation soared 151.29% YoY to Rs6.96bn.

The company reported taxation charges of Rs2.78bn, sharply higher by 147.83% YoY, leaving a net profit of Rs4.20bn, compared to Rs1.65bn in SPLY.

Alongside the results, the Board of Directors informed an interim cash dividend of Rs5 per share

Copyright Mettis Link News